Yu Mei

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately.

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately.

Journal: Immunology

Published: April 02, 2026

Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma.

Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma.

Journal: Nature communications

Published: October 01, 2025

Targeting intratumoral regulatory T cells by CD137 aptamer-shRNA chimeras.

Targeting intratumoral regulatory T cells by CD137 aptamer-shRNA chimeras.

Journal: Immunotherapy advances

Published: July 04, 2025

Development of a nanoparticle-based immunotherapy targeting CD137 for nasopharyngeal carcinoma treatment.

Development of a nanoparticle-based immunotherapy targeting CD137 for nasopharyngeal carcinoma treatment.

Journal: Theranostics

Published: April 21, 2025

Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies.

Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies.

Journal: Vaccines

Published: March 21, 2025

Targeting Treg-fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma.

Targeting Treg-fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma.

Journal: Gut

Published: February 13, 2025

Calpain 2 regulates IL-1α secretion and inhibits tumor development via modulating calpain 1 expression in the tumor microenvironment.

Calpain 2 regulates IL-1α secretion and inhibits tumor development via modulating calpain 1 expression in the tumor microenvironment.

Journal: Oncoimmunology

Published: January 13, 2025

Induction of cell death in malignant cells and regulatory T cells in the tumor microenvironment by targeting CD137.

Induction of cell death in malignant cells and regulatory T cells in the tumor microenvironment by targeting CD137.

Journal: Oncoimmunology

Published: December 24, 2024

CD137-expressing regulatory T cells in cancer and autoimmune diseases.

CD137-expressing regulatory T cells in cancer and autoimmune diseases.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 07, 2024

IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment.

IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment.

Journal: Cell reports

Published: May 30, 2023

Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production.

Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production.

Journal: Communications biology

Published: July 10, 2022

Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1.

Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1.

Journal: Oncoimmunology

Published: June 27, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026